Herbalife said this week it has agreed to acquire assets from Bioniq, a British company focused on personalized nutritional supplements, in a move aimed at expanding data-based wellness offerings across global markets. Herbalife aims to combine Bioniq's health-data platform with its current manufacturing and distribution capabilities, according to a company statement.
The transaction is expected to close in the second quarter of 2026, subject to regulatory approvals, and Bioniq’s products are slated to launch later this year in select countries in Europe and the United States before expanding to additional markets. Herbalife Worldwide CEO Stephan Gratziani described the move as a strategic step toward offering personalized nutrition solutions on a broader scale.
Building a broader personalized nutrition platform
Founded in London in 2019, Bioniq develops personalized supplement programs using questionnaires, blood tests and a database of biomarkers, according to the statement. The company says its services are used by a broad consumer base as well as professional athletes, including Cristiano Ronaldo, who is also a shareholder in Bioniq.
The acquisition fits into Herbalife’s wider push into personalized health tools. That strategy follows the company’s earlier move described in Herbalife deepens collaboration with Ronaldo, which detailed its effort to combine biometric data with customized nutrition recommendations.
Bioniq founder and president Vadim Fedotov said he launched the company to help people manage their well-being through nutrition tailored to personal health data and lifestyle. Ronaldo said tracking personal metrics and adapting nutrition accordingly can support performance and welcomed the integration of Bioniq’s tools into Herbalife’s wider platform.
Israel market in focus
Herbalife Israel CEO Ron Porat said the deal aligns with growing local awareness of personalized nutrition and wellness. He said the move could strengthen Herbalife’s ability to bring more advanced tools to the Israeli market while supporting distributors and customers with solutions tailored to changing consumer needs.
The expansion also comes as supplement use remains widespread in Israel. Recent Jerusalem Post health coverage, including About 71% of Israelis take dietary supplements, many may be putting themselves at risk and Vitamins without need can be dangerous, has highlighted both strong consumer demand and growing medical scrutiny around unnecessary supplementation.
Herbalife, which says it operates in more than 90 markets, has recently expanded other wellness lines as well, including its skincare rollout covered in New Korean skincare line from Herbalife. The company said the Bioniq deal remains subject to regulatory approval and is expected to close in the second quarter of 2026.